CEFUROXIME FOR INJECTION, USP POWDER FOR SOLUTION

País: Canadà

Idioma: anglès

Font: Health Canada

ingredients actius:

CEFUROXIME (CEFUROXIME SODIUM)

Disponible des:

STERIMAX INC

Codi ATC:

J01DC02

Designació comuna internacional (DCI):

CEFUROXIME

Dosis:

1.5G

formulario farmacéutico:

POWDER FOR SOLUTION

Composición:

CEFUROXIME (CEFUROXIME SODIUM) 1.5G

Vía de administración:

INTRAVENOUS

Unidades en paquete:

20ML

tipo de receta:

Prescription

Área terapéutica:

SECOND GENERATION CEPHALOSPORINS

Resumen del producto:

Active ingredient group (AIG) number: 0122448008; AHFS:

Estat d'Autorització:

APPROVED

Data d'autorització:

2014-03-14

Fitxa tècnica

_ _
Cefuroxime for Injection, USP: Product Monograph_ _
Page 1 of 33
PRODUCT MONOGRAPH
PR
CEFUROXIME FOR INJECTION, USP
750 mg / 10 mL vial
1.5 g / 20 mL vial
7.5 g / 100 mL Pharmacy Bulk Vial
ANTIBIOTIC
SteriMax Inc.
2770 Portland Drive
Oakville, ON
L6H 6R4
Date of Revision:
August 28, 2020
Control No: 242254
_ _
Cefuroxime for Injection, USP - Product Monograph_ _
Page 2 of 33
PRODUCT MONOGRAPH
PR
CEFUROXIME FOR INJECTION, USP
750 mg / 10 mL vial
1.5 g / 20 mL vial
7.5 g / 100 mL Pharmacy Bulk Vial
THERAPEUTIC CLASSIFICATION
Antibiotic
ACTION AND CLINICAL PHARMACOLOGY
_In vitro _studies demonstrate that the bactericidal action of
cefuroxime results from inhibition of
bacterial cell wall synthesis by inhibiting the transpeptidase and
carboxypeptidase enzymes.
INDICATIONS AND CLINICAL USES
TREATMENT
Cefuroxime for Injection, USP may be indicated for the treatment of
patients with infections
caused by susceptible strains of the designated organisms in the
following diseases:
LOWER RESPIRATORY TRACT INFECTIONS:
Pneumonia caused by _Streptococcus pneumoniae, Haemophilus influenzae
_including ampicillin-
resistant strains, _Klebsiella _species, _Staphylococcus aureus
_including ampicillin-resistant (but not
methicillin-resistant) strains, _Streptococcus pyogenes_, and
_Escherichia coli. _
_ _
URINARY TRACT INFECTIONS:
Caused by _Escherichia coli_, and _Klebsiella _species.
SOFT TISSUE INFECTIONS:
Caused by _Staphylococcus aureus, _including ampicillin-resistant (but
not methicillin-resistant)
strains, _Streptococcus pyogenes, Escherichia coli_, and _Klebsiella
_species.
MENINGITIS:
Caused by _Staphylococcus aureus _including ampicillin-resistant (but
not methicillin-resistant)
strains, _Streptococcus pneumoniae, Haemophilus influenzae_, and
_Neisseria meningitidis_.
_ _
Cefuroxime for Injection, USP: Product Monograph_ _
Page 3 of 33
GONORRHEA:
Caused by _Neisseria gonorrhoeae _including ampicillin-resistant
strains.
BONE AND JOINT INFECTIONS:
Caused by _Staphylococcus aureus _(penicillinase and non-penicillinase
pro